When you type a question into ChatGPT, Claude, Gemini or Grok, you probably assume the chatbot is responding directly to your ...
Hackers can hijack ChatGPT, Claude, and Gemini with nothing but a sentence. OpenAI says the problem may never be fully solved.
AI agents have fundamentally changed the threat model of AI model-based applications. By equipping these models with plugins (also called tools), your agents no longer just generate text; they now ...
Most people spend at least four years studying for their bachelor's degree, but now, some students are fast-tracking that process in just weeks using online colleges. Washington Post national ...
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
A security researcher, working with colleagues at Johns Hopkins University, opened a GitHub pull request, typed a malicious instruction into the PR title, and watched Anthropic’s Claude Code Security ...
Many people are turning to artificial intelligence for personal finance advice. Writing a good AI prompt can mean the difference between receiving a reasonable or poor output, experts said. While AI ...
Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.
Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...
Readers of Lucy Score’s new romance novel, “Mistakes Were Made,” will marvel at the cover and sprayed edges. They'll anticipate the love story that awaits them on the pages. But all the excitement in ...
The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...
Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...